The Development of Striatal Compartments: From Proliferation to Patches. In: Carpenter MB, Jayaraman A, editors. The Basal Ganglia II. Boston: Springer US; 1987. pp. 81-98. [DOI: 10.1007/978-1-4684-5347-8_5]

EphA7 expression identifies a unique neuronal compartment in the rat striatum

Prior studies have identified two anatomically and neurochemically distinct cellular compartments within the mammalian striatum, termed striosomes and matrix, which express μ-opioid receptors (μOR) and EphA4, respectively. Here we identify and characterize an additional compartment in the rat striatum composed of neurons that express EphA7. In situ hybridization and immunohistochemical data indicate that neurons expressing EphA7 mRNA and protein are arranged in a banded "matrisome-like" pattern confined to the matrix in the dorsal striatum. Within the ventral striatum, EphA7-positive (+) neurons have a less organized mosaic pattern that partially overlaps areas expressing μOR. Immunolabeling data demonstrate that EphA7+ striatofugal axons form distinct fascicles leaving the striatum. Within the globus pallidus, EphA7+ axons terminate primarily within ventromedial areas of the nucleus and along its striatal border. EphA7+ axons avoid regions containing dopamine neurons within the substantia nigra and preferentially innervate areas near the rostral and caudal margins of the nucleus. Within both nuclei, EphA7+ axons have similar but more restricted terminal fields than the entire population of EphA4+ matrix axons, indicating that EphA7+ axons comprise a subpopulation of matrix axons. Ligand binding data demonstrate that ephrin-A5 selectively binds areas of the striatum, globus pallidus, and substantia nigra containing EphA7+ neurons and axons, but not areas expressing only EphA4. Our findings demonstrate that EphA7 expression identifies a novel "matrisome" compartment within the matrix that binds ephrin-A5 and possesses unique axonal projections. Our findings also suggest that EphA7 and ephrin-A5 may participate in the formation of this matrisome subcompartment and its striatofugal projections.

The neostriatal mosaic: basis for the changing distribution of neurokinin-1 receptor immunoreactivity during development

The pattern of neurokinin-1 receptor-like immunoreactivity (NK-1Rir) was mapped in perinatal and adult mouse striatum by using a new polyclonal antiserum. NK-1Rir was detected in the differentiating regions of the ganglionic eminences on embryonic day 12.5 (E12.5). NK-1Rir structures were enriched in the striatal patch compartment between E16.5 and approximately postnatal day 3 (P3); distributed more uniformly, within portions of both the patch and matrix compartments on P7; and enriched in the matrix compartment in the adult. Analysis of the phenotype of NK-1Rir cells on P2, P7, and in the adult suggested that cholinergic cells accounted for the majority of NK-1Rir cells early postnatally, with increasing contributions from somatostatinergic cells later postnatally. In the adult, approximately half of NK-1Rir cells were cholinergic and half were somatostatinergic. The transient enrichment of NK-1R-bearing cells and processes in the patch compartment which contains cells that express substance P (SP), a putative ligand for the NK-1R, may be a consequence of compartment formation or may be functionally important for compartment development.

Patchy distribution of substance P receptor immunoreactivity in the' developing rat striatum

Developmental changes of the distribution pattern of substance P receptor (SPR) were investigated immunohistochemically in the rat striatum. The SPR immunoreactivity in the striatum first emerged at postnatal day 1 and transiently showed a patchy pattern of distribution until it displayed the adult pattern of homogeneous distribution by the third postnatal week. The SPR-immunoreactivity patches were most marked in the medial and dorsolateral parts of the striatum, as well as in the subcallosal streak. They matched tyrosine hydroxylase-enriched areas and, conversely, avoided calbindin-enriched zones. No neurons within the SPR-immunoreactive patches contained either choline acetyltransferase or somatostatin, which is known to be contained in intrinsic neurons in the striatum. The vast majority of SPR-immunoreactive patch neurons also contained DARPP-32, a phosphoprotein that is expressed in striatal projection neurons with D1 dopamine receptor. The results indicate that SPR-immunoreactive patches which appear transiently in the developing striatum are in register with the striatal patch compartment, and that SPR immunoreactivity within these patches may be expressed on projection neurons rather than intrinsic neurons. Such SPR immunoreactivity in projection neurons in striatal patches may fade out in adulthood.

Ontogeny of the striatal neurons expressing the D1 dopamine receptor in humans

We studied D1 dopamine receptor (D1R) gene expression in the human striatum during ontogeny by in situ hybridization, immunohistochemistry, and D1R ligand autoradiography. D1R mRNA, protein, and binding sites ([3H]SCH 23390) were detected in the striatum from week 12 of fetal life. At this time, D1R mRNA was predominant in the striosomal neurons; D1R immunoreactivity (D1R-IR) and D1R binding sites displayed a pattern similar to D1R mRNA. D1R-IR was essentially present in striosomal cell bodies and neuropil, whereas only a few cell bodies were detected in the matrix. From week 20 of fetal life, D1R gene expression developed in the matrix neurons as well, thus leading to an even D1R mRNA expression throughout striosomes and matrix compartments at birth. Comparative analysis of the expression of D1R and dynorphin mRNA show the same developmental patchy pattern up to week 26. Indeed, neurons expressing the D1R gene contain dynorphin mRNA; in contrast, they do not express the preproenkephalin A gene. At birth, the pattern of D1R mRNA expression level was sharply different from that of dynorphin (DYN) gene expression. High DYN mRNA expression was restricted to the striosomes, whereas high D1R mRNA expression was present in the whole striatum. These results demonstrate that, during human ontogeny, functional D1 receptors are expressed as early as week 12 in the striatum, developing initially in the striosomal neurons containing high dynorphin mRNA content. Toward the end of fetal life, there is a dissociation between D1R and DYN expression levels, suggesting that neuroanatomical or neurochemical modifications occur at this period, which may contribute to the regulation of the tone of the striatal D1R and DYN gene with topological specificity.

Pattern formation in the mammalian forebrain: striatal patch and matrix neurons intermix prior to compartment formation

The striatum of the mammalian forebrain is divided into two compartments: the patches and the matrix. Neurons of the patch compartment in the rat striatum become postmitotic earlier in neurogenesis than neurons of the matrix compartment. The selective adhesion of patch neurons to one another has been suggested previously to be an important developmental mechanism of striatal compartmentation. We asked if the selective adhesion of patch neurons is expressed before or after the migration of the majority of the matrix neurons into the striatum. Patch neurons were labelled in vivo by a fluorescent retrograde tracer injected into the substantia nigra on embryonic day 19, which almost exclusively labelled patch neurons. Matrix neurons were labelled with a maternal injection of bromodeoxyuridine at embryonic day 18. When animals were killed at embryonic day 20, the majority of the retrogradely labelled patch neurons were intermixed with the bromodeoxyuridine-labelled matrix neurons, although there appeared to be clustering of some of the patch neurons. However, by postnatal day 2 there was a complete segregation of the clusters of the retrogradely labelled patch neurons from the bromodeoxyuridine-labelled matrix neurons in the striatum. This process was modelled in vitro. The patch and matrix compartments were labelled in vivo at embryonic day 13 and 18 respectively, with different birthdate markers ([3H]thymidine or bromodeoxyuridine). At embryonic day 20 the striatal tissue was removed, dissociated and reaggregated in suspension cultures. After 1 day in vitro, labelled patch and matrix neurons were randomly intermixed within the reaggregates. Examination of the cultures at 2.5 and 4 days in vitro revealed clumping of the labelled patch neurons towards the centres of the reaggregates. Over this same period, the labelled matrix neurons did not clump and were dispersed towards the periphery of the reaggregates. The results suggest that patch neuron adhesiveness may appear relatively soon after these neurons become postmitotic, but that this adhesiveness is unable to overcome the initial force produced by the massive migration of matrix neurons into the striatum. We hypothesize that a migratory phase of embryonic striatal development exists, when fated patch and matrix neurons intermix. After this migratory phase, patch neuron adhesiveness can produce the mature segregation of the striatal compartments.